TalkMed Group Statistics

Total Valuation

TalkMed Group has a market cap or net worth of SGD 591.47 million. The enterprise value is 509.89 million.

Market Cap	591.47M
Enterprise Value	509.89M

Important Dates

The next estimated earnings date is Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	n/a

Share Statistics

TalkMed Group has 1.33 billion shares outstanding. The number of shares has increased by 0.51% in one year.

Current Share Class	n/a
Shares Outstanding	1.33B
Shares Change (YoY)	+0.51%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	85.42%
Owned by Institutions (%)	n/a
Float	193.74M

Valuation Ratios

The trailing PE ratio is 13.61.

PE Ratio	13.61
Forward PE	n/a
PS Ratio	7.55
PB Ratio	7.04
P/TBV Ratio	7.04
P/FCF Ratio	20.82
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.86, with an EV/FCF ratio of 17.95.

EV / Earnings	11.64
EV / Sales	6.52
EV / EBITDA	10.86
EV / EBIT	11.65
EV / FCF	17.95

Financial Position

The company has a current ratio of 3.68, with a Debt / Equity ratio of 0.11.

Current Ratio	3.68
Quick Ratio	3.62
Debt / Equity	0.11
Debt / EBITDA	0.25
Debt / FCF	0.31
Interest Coverage	163.62

Financial Efficiency

Return on equity (ROE) is 52.83% and return on invested capital (ROIC) is 22.47%.

Return on Equity (ROE)	52.83%
Return on Assets (ROA)	18.01%
Return on Invested Capital (ROIC)	22.47%
Return on Capital Employed (ROCE)	40.00%
Revenue Per Employee	336,987
Profits Per Employee	188,763
Employee Count	232
Asset Turnover	0.70
Inventory Turnover	24.52

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.92% in the last 52 weeks. The beta is 0.15, so TalkMed Group's price volatility has been lower than the market average.

Beta (5Y)	0.15
52-Week Price Change	+21.92%
50-Day Moving Average	0.45
200-Day Moving Average	0.43
Relative Strength Index (RSI)	46.04
Average Volume (20 Days)	29,075

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TalkMed Group had revenue of SGD 78.18 million and earned 43.79 million in profits. Earnings per share was 0.03.

Revenue	78.18M
Gross Profit	44.72M
Operating Income	32.07M
Pretax Income	49.44M
Net Income	43.79M
EBITDA	33.10M
EBIT	32.07M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 82.78 million in cash and 8.71 million in debt, giving a net cash position of 74.07 million or 0.06 per share.

Cash & Cash Equivalents	82.78M
Total Debt	8.71M
Net Cash	74.07M
Net Cash Per Share	0.06
Equity (Book Value)	76.46M
Book Value Per Share	0.06
Working Capital	71.26M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 28.80 million and capital expenditures -394,000, giving a free cash flow of 28.41 million.

Operating Cash Flow	28.80M
Capital Expenditures	-394,000
Free Cash Flow	28.41M
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 57.20%, with operating and profit margins of 41.02% and 56.01%.

Gross Margin	57.20%
Operating Margin	41.02%
Pretax Margin	63.23%
Profit Margin	56.01%
EBITDA Margin	42.34%
EBIT Margin	41.02%
FCF Margin	36.34%

Dividends & Yields

This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 8.09%.

Dividend Per Share	0.04
Dividend Yield	8.09%
Dividend Growth (YoY)	50.00%
Years of Dividend Growth	1
Payout Ratio	109.06%
Buyback Yield	-0.51%
Shareholder Yield	7.58%
Earnings Yield	7.40%
FCF Yield	4.80%

Dividend Details

Stock Splits

The last stock split was on April 28, 2017. It was a forward split with a ratio of 2.

Last Split Date	Apr 28, 2017
Split Type	Forward
Split Ratio	2

Scores

TalkMed Group has an Altman Z-Score of 14.07.

Altman Z-Score	14.07
Piotroski F-Score	n/a